Compare PPCB & KUST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PPCB | KUST |
|---|---|---|
| Founded | 2007 | 2004 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | | Radio And Television Broadcasting And Communications Equipment |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7M | 4.6M |
| IPO Year | N/A | N/A |
| Metric | PPCB | KUST |
|---|---|---|
| Price | $0.22 | $1.71 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 565.5K | ★ 7.0M |
| Earning Date | 02-15-2026 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $19,097,965.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.38 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.24 | $1.80 |
| 52 Week High | $145.46 | $1,799.40 |
| Indicator | PPCB | KUST |
|---|---|---|
| Relative Strength Index (RSI) | 27.01 | 41.20 |
| Support Level | $0.24 | $1.80 |
| Resistance Level | $0.40 | $2.53 |
| Average True Range (ATR) | 0.06 | 0.45 |
| MACD | 0.01 | -0.04 |
| Stochastic Oscillator | 7.08 | 0.36 |
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.